May 23, 2025, China - As a global leader in plant-based capsule technology, Healsee has once again demonstrated its strong supply chain capabilities by steadily shipping over 30 containers of premium plant-based capsules to the European market in May 2025, further solidifying its prominent position in Europe's healthcare and pharmaceutical sectors. Each container carries approximately 360 cartons of products, totaling over 700 million capsules, including best-selling formulations such as plant-based vitamins, probiotics, and functional health products. This shipment fully meets the growing European demand for natural and sustainable health solutions.
Europe, being one of the world's most critical markets for healthcare products, imposes stringent requirements on product quality and supply chain reliability. Healsee has earned long-term trust from European partners through its advanced plant-based capsule technology, strict GMP production standards, and compliance with EU regulatory certifications. This large-scale, consistent supply not only highlights Healsee's robust production capacity and logistical efficiency but also underscores its unwavering commitment to deepening its presence in the European market.
The Director of International Business at Healsee stated, "Europe is a cornerstone of Healsee's global strategy. We will continue to increase R&D investments and optimize supply chain efficiency to provide European customers with more effective and sustainable health product solutions." With the rising global demand for plant-based products, the successful shipment of over 30 containers further strengthens Healsee's foundation for expanding its footprint in Europe and beyond.
